ATE143805T1 - Arzneizubereitung mit hohem gehalt an ibuprofenlysinat - Google Patents

Arzneizubereitung mit hohem gehalt an ibuprofenlysinat

Info

Publication number
ATE143805T1
ATE143805T1 AT92302372T AT92302372T ATE143805T1 AT E143805 T1 ATE143805 T1 AT E143805T1 AT 92302372 T AT92302372 T AT 92302372T AT 92302372 T AT92302372 T AT 92302372T AT E143805 T1 ATE143805 T1 AT E143805T1
Authority
AT
Austria
Prior art keywords
ibuprofenlysinate
high content
medicinal preparation
ibuprofen lysinate
preparation
Prior art date
Application number
AT92302372T
Other languages
English (en)
Inventor
Ashok V Katdare
Chungy Lui
Scott N Kleinhart
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE143805T1 publication Critical patent/ATE143805T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AT92302372T 1991-03-22 1992-03-19 Arzneizubereitung mit hohem gehalt an ibuprofenlysinat ATE143805T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67361391A 1991-03-22 1991-03-22

Publications (1)

Publication Number Publication Date
ATE143805T1 true ATE143805T1 (de) 1996-10-15

Family

ID=24703387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92302372T ATE143805T1 (de) 1991-03-22 1992-03-19 Arzneizubereitung mit hohem gehalt an ibuprofenlysinat

Country Status (10)

Country Link
US (1) US5622990A (de)
EP (1) EP0505180B1 (de)
JP (1) JPH0774154B2 (de)
AT (1) ATE143805T1 (de)
CA (1) CA2063689C (de)
DE (1) DE69214333T2 (de)
DK (1) DK0505180T3 (de)
ES (1) ES2093192T3 (de)
GR (1) GR3021320T3 (de)
IE (1) IE75887B1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2150355C (en) * 1992-12-02 2008-03-11 Robert Hardy Process of resolving phenylpropionic acids using alpha-methylbenzylamine
IT1264855B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
ES2121213T3 (es) * 1993-07-15 1998-11-16 Pfizer Benciloxiquinuclidinas como antagonistas de la sustancia p.
US6342530B1 (en) 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
US6344479B1 (en) 2001-03-20 2002-02-05 Farmacon-Il, Llc Method of preventing retinopathy of prematurity in a neonate
US6551615B1 (en) 2001-10-18 2003-04-22 M/S. Strides Arcolab Limited Dexibuprofen-containing soft gelatin capsules and process for preparing the same
MX2008010101A (es) * 2006-02-06 2009-02-27 Pharmaceutical Solutions Inc Preparaciones antiinflamatorias no esteroides orales líquidas y en polvo para administración en animales.
CN101544572B (zh) * 2008-03-26 2013-03-20 连云港恒邦医药科技有限公司 一种氨溴索衍生物及其制备方法
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
US20120294937A1 (en) 2009-12-29 2012-11-22 Novartis Ag New pharmaceutical dosage form for the treatment of gastric acid-related disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1497044A (en) * 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
ZA855250B (en) * 1984-08-17 1986-02-26 Upjohn Co Stable,high dose,high bulk density ibuprofen granulations for tablet and capsule manufacturing
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US4994604A (en) * 1990-01-10 1991-02-19 Merck & Co., Inc. Formation and resolution of ibuprofen lysinate
US5087454A (en) * 1990-07-30 1992-02-11 American Home Products Corporation Ibuprofen tablet

Also Published As

Publication number Publication date
IE75887B1 (en) 1997-09-24
DK0505180T3 (da) 1997-03-24
DE69214333D1 (de) 1996-11-14
EP0505180A1 (de) 1992-09-23
JPH0597667A (ja) 1993-04-20
JPH0774154B2 (ja) 1995-08-09
GR3021320T3 (en) 1997-01-31
ES2093192T3 (es) 1996-12-16
US5622990A (en) 1997-04-22
DE69214333T2 (de) 1997-04-24
CA2063689A1 (en) 1992-09-23
IE920913A1 (en) 1992-09-23
CA2063689C (en) 1999-05-04
EP0505180B1 (de) 1996-10-09

Similar Documents

Publication Publication Date Title
ES2080796T5 (es) Formulaciones de productos farmaceuticos de liberacion prolongada.
ATE122033T1 (de) Cyancrotonsäureamidverbindung als arzneimittel mit immunmodulierenden eigenschaften.
NO176550C (no) Fremgangsmåte for fremstilling av stabile, pressede, farmasöytiske formuleringer inneholdende en forbindelse
ATE134134T1 (de) Feste arzneizubereitungen zur oralen verabreichung mit verlängerter magenverweilzeit
DE69231965D1 (de) Pharmazeutische formulierungen
DE69212879T2 (de) Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
IT1150608B (it) Complessi platino-diamminici e procedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi
DK515489A (da) Dispergerbar laegemiddelformulering
FR2682040B1 (fr) Medicaments pour traiter les troubles gastrointestinaux.
ATE143805T1 (de) Arzneizubereitung mit hohem gehalt an ibuprofenlysinat
DE69229710T2 (de) Esterbindung enthaltende Polymere für pharmazeutische Zubereitungen
DK0437294T3 (da) Orale farmaceutiske præparater i enhedsdosisform
ITTO920303A0 (it) "composizione farmaceutica antiinfiammatoria"
ES2054089T3 (es) Formulaciones orales liquidas.
NO180450C (no) Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin
NO951933L (no) Farmasöytiske formuleringer av ibuprofen
ITMI913510A0 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
MX9205454A (es) Composicion farmaceutica para administracion oral al tracto gastrointestinal que comprende calcitonina
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
DE69131521T2 (de) Alpha-Ergocryptine enthaltende pharmazeutische Zusammensetzungen mit nervenschützender Wirkung
IT8719221A0 (it) Composizioni farmaceutiche contenenti levodopa metil estere, loro prodecimento di preparazione e relative applicazioni terapeutiche.
ATE21701T1 (de) Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate.
DE69325531T2 (de) Oral anzuwendendes Arzneimittel bestehend aus Ibuprofen
IT8219453A0 (it) Composizione farmaceutica adattivita' analgesica, antipiretica e antiinfiammatoria e procedimento per la preparazione del principio attivo.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification